CFTR mutations in the Algerian population.

Area of Science:

• Medical Genetics
• Human Molecular Genetics
• Population Genetics

Background:

• The spectrum of cystic fibrosis transmembrane conductance regulator (CFTR) mutations in North Africa is not well-defined.
• Previous studies in Algeria and Tunisia noted European mutations like F508del, G542X, and N1303K, suggesting population admixture.
• Unique CFTR mutations have also been observed in these populations.

Purpose of the Study:

• To genetically characterize cystic fibrosis (CF) patients in Algeria.
• To identify CFTR mutations for improved diagnostic services and risk assessment.
• To investigate CFTR mutations in Algerian males with obstructive azoospermia.

Main Methods:

• Genotyping of 81 Algerian CF patients using D-HPLC, chemical-clamp denaturing gradient gel electrophoresis, multiplex amplification, and direct DNA sequencing.
• Screening for exon deletions/duplications using quantitative multiplex PCR short fragment fluorescence analysis.
• Clinical evaluation of homozygous CF patients and investigation of 46 unrelated Algerian males with obstructive azoospermia.

Main Results:

• Identification of 15 distinct CFTR mutations, explaining 58.5% of CF chromosomes in the studied Algerian cohort.
• Detection of CFTR mutations in Algerian individuals with obstructive azoospermia.
• Characterization of clinical phenotypes in homozygous CF patients.

Conclusions:

• This study provides the first comprehensive genetic and clinical evaluation of CF patients in Algeria.
• The findings highlight the importance of identifying specific CFTR mutation profiles for effective CF management in North Africa.
• Further research is warranted to understand the full spectrum and impact of CFTR mutations in this region.